TY - JOUR T1 - Mixtard 30 - going, going, gone? JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 85 LP - 85 DO - 10.1136/dtb.2010.08.0040 VL - 48 IS - 8 A2 - , Y1 - 2010/08/01 UR - http://dtb.bmj.com/content/48/8/85.abstract N2 - In June 2010, the drug company Novo Nordisk announced that its only conventional human biphasic insulin, human Mixtard 30, would no longer be available in the UK from January 2011, a decision that affects an estimated 90,000 patients. The alternative biphasic analogue insulins are more expensive than Mixtard 30. Assuming a direct swap to Novo Nordisk's analogue biphasic insulin, NovoMix 30, the increased prescribing costs could be over … ER -